Johann Holzmann

Title: Johann Holzmann: Innovator in Genetic Engineering

Introduction

Johann Holzmann is a notable inventor based in Kundl, Austria. He has made significant contributions to the field of genetic engineering, particularly in the development of nucleic acids and their applications in medicine. With a total of 4 patents to his name, Holzmann's work is paving the way for advancements in therapeutic proteins.

Latest Patents

Holzmann's latest patents include a groundbreaking invention related to a DNA coding sequence for human granulocyte-colony stimulating factor (G-CSF). This invention focuses on a nucleic acid that encodes human G-CSF, ensuring that the first leucine residue on the N-terminal end is encoded by a codon other than the CTG/CUG codon. Additionally, the nucleic acid does not comprise specific sequences outlined in SEQ ID NO: 1 through SEQ ID NO: 4. The invention also encompasses a nucleic acid that is 100% complementary to the aforementioned sequence, along with vectors and host cells that utilize these nucleic acids. Furthermore, Holzmann's work includes methods for producing human G-CSF using these innovative nucleic acids, vectors, and host cells, leading to effective G-CSF compositions.

Another significant patent addresses the issue of amino acid residue misincorporations found in sequence variants. This invention provides a method for optimizing coding sequences of polynucleotides that encode polypeptides, particularly focusing on codons susceptible to misincorporation. This method can reverse-engineer unknown coding sequences that encode the same polypeptide but differ in specific codons. It also has the potential to alter the immunogenic properties of expressed polypeptides, making it a valuable tool in the engineering of optimized polynucleotides.

Career Highlights

Holzmann is currently associated with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. His work at Sandoz AG has allowed him to apply his innovative ideas in a practical setting, contributing to the development of new therapeutic solutions.

Collaborations

Throughout his career, Holzmann has collaborated with esteemed colleagues such as Michael Fuchs and Alfred Rupprechter. These collaborations have further enriched his research and development efforts, leading to impactful innovations in the field.

Conclusion

Johann Holzmann's contributions to genetic